Search results (388)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
OCION: In conversation with Audrey Gerard
13 January 2025
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with OCION Pump-Prime Awardee, Associate Professor Audrey Gerard, to discuss her research.
Oxford researchers develop blood test to enable early detection of multiple cancers
8 January 2025
Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Alethiomics – using Artemis to hunt down blood cancers
6 January 2025
Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists who run neighbouring laboratories at the University’s MRC Weatherall Institute of Molecular Medicine, seed financed by Oxford Science Enterprises and located at the BioEscalator, the company’s early years have been immersed in the Oxford innovation ecosystem.
Predicting Response to Rectal Cancer Treatment through the S:CORT consortium
5 December 2024
Recent research from the S:CORT team spanning three publications has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment.
OCION: In conversation with Adán Pinto-Fernández
3 December 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Dr. Adán Pinto-Fernández to discuss his research.
Register for the 2025 Oxford Cancer Symposium!
29 November 2024
The Oxford Cancer Symposium supported by the CRUK Oxford Centre is the crowning event in the Oxford Cancer calendar. With approximately 300 people attending in person each year, it provides an opportunity for our members to network and build new collaborations.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.
MyMelanoma study selected to join NHS DigiTrials initiative
15 November 2024
Three projects – including the Oxford-led MyMelanoma study - have been selected to join an NHS initiative, which aims to sign up tens of thousands of volunteers over the next two years to help improve the diagnosis and treatment of cancer patients.
2024 OCION Pump Prime Awardees Named
14 November 2024
Congratulations to the 2024 OCION Pump Prime Awardees, funded by the CRUK Oxford Centre and NIHR Oxford BRC
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
8 November 2024
Analysis of 17.5 million health records reveals significant ethnic and social inequalities in lung cancer diagnosis. Research shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas. Important implications for NHS screening.
Oxford WntUK meeting 2025
7 November 2024
Join us in Oxford to celebrate UK and international Wnt research, network, forge future collaborations, meet old and new friends, and to make our shared dream of a UK-wide Wnt society a reality.
COMBATcancer at the HIPP Summer School 2024
1 November 2024
Aleksandra Dzhoneva - Postdoctoral Scientist- shares her experience at the HIPP Summer School 2024, which she attended to present research as part of the COMBATcancer consortium. Her attendance was fully funded by Oxford Cancer.
OxCODE researchers at the Early Detection of Cancer Conference 2024
25 October 2024
Oxford’s early detection research was featured at this annual event.
'Oxford LIVer cancer centre of Excellence' Launched
24 October 2024
To mark liver cancer awareness month, we are excited to announce the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
Dr Bo Sun awarded Future Leaders Grant
15 October 2024
The three-year £225,000 grant from The Brain Tumour Charity will fund research into whether it's possible to use T-cells to track and detect gliomas.
UK cancer registry data is as accurate and timely as on-site trial data, new study shows
11 October 2024
Researchers from the Cancer Theme at Nuffield Department of Primary Care Health Sciences (NDPCHS) and Department of Oncology at the University of Oxford, report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
OCION: In conversation with Alfred Zippelius
7 October 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Alfred Zippelius to discuss his research.
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
Pseudouridine landscape across the human transcriptome mapped
2 October 2024
The Song group at Ludwig Oxford in the Nuffield Department of Medicine have published a technique for mapping the pseudouridine landscape across the human transcriptome.